03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Rapifen* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Janssen |
Responsible Party | Janssen Pharmaceutica NV |
Origin | Belgium |
Manufacturer | Janssen Pharmaceutica NV |
Origin | Belgium |
ATC | N01AH02 |
Revision Date | 01/05/2008 |
Rapifen* :
Rapifen* :
Rapifen* :
Rapifen* :
Rapifen* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agitation | Rare |
Agitation postoperative | Uncommon |
Airway complication of anaesthesia | Uncommon |
Anaesthetic complication neurological | Rare |
Anaphylactic reactions | Not known |
Anaphylactoid reactions | Not known |
Apnoea (Apnea) | Common |
Arrhythmia | Uncommon |
Bradycardia | Common |
Bronchospasm | Rare |
Cardiac arrest | Not known |
Cephalea | Uncommon |
Chills | Common |
Confusion postoperative | Uncommon |
Convulsion | Not known |
Cough | Not known |
Crying | Rare |
Dermatitis allergic | Uncommon |
Disorientation | Not known |
Dyskinesia | Common |
Endotracheal intubation complication | Rare |
Epistaxis (Nasal bleeding) | Rare |
Erythema | Not known |
Euphoric mood | Common |
Fatigue | Common |
Fever | Not known |
Heart rate decreased | Uncommon |
Hiccups | Uncommon |
Hypercapnia | Uncommon |
Hyperhidrosis | Uncommon |
Hypersensitivity | Not known |
Hypertension | Common |
Hypotension | Common |
Injection site pain | Common |
Laryngospasm | Uncommon |
Lightheadedness | Common |
Miosis | Not known |
Movement disorder | Common |
Muscle rigidity | Common |
Myoclonus | Not known |
Nausea | Very Common |
Pain | Uncommon |
Postoperative unconsciousness | Not known |
Procedural complication | Rare |
Procedural pain | Common |
Pruritus | Rare |
Respiratory arrest | Not known |
Respiratory depression | Uncommon |
Sedation | Common |
Skin Eruption | Not known |
Somnolence | Uncommon |
Tachycardia | Common |
Unresponsive to stimuli | Uncommon |
Urticaria | Not known |
Vein pain | Rare |
Visual disturbance | Common |
Vomiting | Very Common |
Rapifen* :
NB : Products With Same Indication |
Different Units By MoH Code
Rapifen* MoH 2629 :
Form | Solution for injection |
Packaging | Ampoules |
Package Size | 5x2ml |
Strength | 0.5mg/ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27148 |
Submission date | 01/01/1992 |
Registration Year | 1992 |
Archived Date | 2014 |
Price Comparison
● Country: | Finland | |
● Package Size: | 5x2ml | |
● Public Price: | 12.98 EUR | ( 1,257,450.48 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 2,596 EUR | ( 193,752.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 5x2ml | |
● Public Price: | 10.78 EUR | ( 1,044,323.28 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 2,156 EUR | ( 193,752.00 LBP ) |
● Pharmacy Price: | 3.78 EUR | ( 366191.28 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 5x2ml | |
● Public Price: | 97.2 NOK | ( 787,708.80 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 19,44 NOK | ( 153,976.00 LBP ) |
● Pharmacy Price: | 33.06 NOK | ( 267918.24 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 03/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 5x2ml | |
● Public Price: | 147.69 CZK | ( 564,028.11 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 29,538 CZK | ( 110,751.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1x2ml | |
● Public Price: | 3.17 AED | ( 76,590.37 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3,17 AED | ( 72,483.00 LBP ) |
● Pharmacy Price: | 2.76 AED | ( 66684.36 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 2ml | |
● Public Price: | 19.45 SAR | ( 459,798.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 3,89 SAR | ( 70,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 30x2ml | |
● Public Price: | 13 EUR | ( 1,259,388.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,4333 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 10x2ml | |
● Public Price: | 6.34 GBP | ( 720,534.66 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 0,634 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | France |
● Package Size: | 5x2ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
● Country: | Denmark |
● Package Size: | 5x2ml |
● Reference: | Danish Medicine Agency |
● Pricing Date: | 21/10/2020 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Rapifen* MoH 2642 :
Form | Solution for injection |
Packaging | Ampoules |
Package Size | 5x10ml |
Strength | 0.5mg/ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27149 |
Submission date | 01/01/1992 |
Registration Year | 1992 |
Archived Date | 2014 |
Price Comparison
● Country: | Finland | |
● Package Size: | 5x10ml | |
● Public Price: | 55.5 EUR | ( 5,376,618.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 11,1 EUR | ( 1,065,636.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 5x10ml | |
● Public Price: | 25.93 EUR | ( 2,511,994.68 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 5,186 EUR | ( 484,380.00 LBP ) |
● Pharmacy Price: | 18.93 EUR | ( 1833862.68 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1x10ml | |
● Public Price: | 18.6 AED | ( 449,394.60 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 18,6 AED | ( 434,898.00 LBP ) |
● Pharmacy Price: | 16.17 AED | ( 390683.37 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 5x10ml | |
● Public Price: | 249.2 NOK | ( 2,019,516.80 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 49,84 NOK | ( 397,096.00 LBP ) |
● Pharmacy Price: | 152.28 NOK | ( 1234077.12 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 03/06/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 10ml | |
● Public Price: | 82.95 SAR | ( 1,960,938.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 16,59 SAR | ( 378,240.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 5x10ml | |
● Public Price: | 16 GBP | ( 1,818,384.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 3,2 GBP | ( 340,947.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 50x10ml | |
● Public Price: | 111 EUR | ( 10,753,236.00 LBP ) |
● Pack size unit used: | 50 | |
● Cost/Unit: | 2,22 EUR | ( 193,752.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | France |
● Package Size: | 10x10ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
● Country: | Denmark |
● Package Size: | 5x10ml |
● Reference: | Danish Medicine Agency |
● Pricing Date: | 19/05/2021 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File